Systematic review: The use of somatostatin or octreotide in refractory diarrhoea

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 12, 2001, Pages 1889-1897

  Szilagyi, A ^a   Shrier, I ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; STATISTICAL ANALYSIS;

ANTIDIARRHEALS; CASE-CONTROL STUDIES; DIARRHEA; EVIDENCE-BASED MEDICINE; HUMANS; MEDLINE; META-ANALYSIS; OCTREOTIDE; RANDOMIZED CONTROLLED TRIALS; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 0035666154     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01114.x     Document Type: Article

References (58)

1. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro
2. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
3. Somatostatin and somatostatin analogues pharmacokinetics and pharmacodynamic effects
4. Octreotide
5. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide
6. Octreotide in the treatment of refractory diarrhea
7. Octreotide in the treatment of refractory diarrhea and intestinal fistulas
8. Stretching before exercise: An evidence-based approach
9. Problems in the 'evidence' of 'evidence-based medicine'
10. Vasoactive intestinal polypeptide (VIP) secretion and refractory diarrhea in patients with AIDS or AIDS-related complex (ARC)
11. Treatment of AIDS-related refractory diarrhea with octreotide
12. Octreotide treatment in secretory and cryptosporidial diarrhea in patients with acquired immunodeficiency syndrome (AIDS): Clinical evaluation
13. Pilot study of sandostatin (octreotide) therapy of refractory HIV-associated diarrhea
14. Effect of octreotide on refractory AIDS-associated diarrhea
15. Efficacy of octreotide in the management of chronic diarrhea in AIDS
16. Octreotide therapy in AIDS-related refractory diarrhea: Results of a multicenter Canadian-European study
17. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhea: Dose finding study and evaluation of efficacy
18. Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorin
19. Phase I trial of the somatostatin analog octreotide acetate in the treatment of fluoropyrimidine-induced diarrhea
20. Bowel rest, intravenous hydration and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma
21. Control of chemotherapy-induced diarrhea with octreotide in patients receiving 5-fluorouracil
22. Use of octreotide in the symptomatic management of diarrhea induced graft-versus-host disease in patients with hematologic malignancies
23. Octreotide acetate in refractory bone marrow transplant-associated diarrhea
24. Use of somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease
25. Treatment of severe post vagotomy/post gastrectomy symptoms with the somatostatin analogue octreotide
26. Octreotide (a little somatostatin analogue) improves the quality of life in some patients with a short intestine
27. Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome
28. Treatment of refractory diarrhea in AIDS with acetorphan and octreotide: A randomized cross over study
29. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: A randomized controlled trial
30. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea
31. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: A randomized trial
32. Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy
33. Control of chemotherapy-induced diarrhea with octreotide
34. Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients
35. Efficacy of octreotide in diarrhea due to vibrio cholerae: A randomized, controlled trial
36. Effect of intravenous somatostatin on stool output in diarrhea due to vibrio cholerae
37. Efficacy of octreotide acetate in treatment of severe post gastrectomy dumping syndrome
38. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome
39. Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhea
40. Somatostatin inhibits diarrhea in the carcinoid syndrome
41. Treatment of the malignant carcinoid syndrome: Evaluation of a long-acting somatostatin analogue
42. Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome
43. Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes
44. Effect of somatostatin on ion transport in the rat colon
45. Somatostatin inhibits fluid secretion in the rat jejunum
46. Somatostatin stimulates sodium and chloride absorption in the rat ileum
47. In vitro effects of the long-acting somatostatin analogue SMS 201-995 on electrolyte transport by the rabbit ileum
48. Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel
49. Peptides of human immunodeficiency virus (HIV) evoke rat colonic electrolyte secretion inhibitable by the somatostatin analog octreotide
50. SMS 201-995, a somatostatin analogue, and diarrhea in the acquired immunodeficiency syndrome AIDS
51. Somatostatin decreases diarrhea in patients with the short-bowel syndrome
52. Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995
53. Effective treatment of diabetic diarrhea with somatostatin analogue, octreotide
54. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension
55. Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration
56. An open trial of octreotide long-acting release in the management of short bowel syndrome
57. Consensus statement: Octreotide dose titration in secretory diarrhea